STZ expected to report higher earnings, outperforming industry, while ANGO expected to face challenges

From Nasdaq: 2024-10-02 16:00:01

On 10/03/2024, Constellation Brands Inc (STZ) is set to report earnings for the quarter ending August 31, 2024. Analysts predict an earnings per share of $4.11, an 11.08% increase from last year. With a 2025 Price to Earnings ratio of 19.05, STZ is expected to outperform competitors in the industry.

AngioDynamics, Inc. (ANGO) will also report earnings for the quarter ending August 31, 2024, with a consensus earnings per share forecast of $-0.15, a 25.00% decrease from the same quarter last year. ANGO’s 2025 Price to Earnings ratio is -18.61, compared to industry ratio of 8.50, indicating a challenging year ahead for the medical instruments company.



Read more at Nasdaq:: Pre-Market Earnings Report for October 3, 2024 : STZ, ANGO